(MENAFNEditorial) YARDLEY, Pa., Dec. 07, 2017 (GLOBE NEWSWIRE) -- (NASDAQ:), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive Officer will present at the December 14, 2017, at 9 am ET in New York. To listen to a webcast of the presentation live, please visit the of the Optinose website. A replay of the webcast will be available for 90 days following the conclusion of the event.
About Optinose®
Optinose is a specialty pharmaceutical company on a mission to improve lives with a focus on patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has corporate offices in the U.S., the U.K. and Norway. To learn more, please visit .
Optinose Media Contact
Kate Traynor, Sloane & Company
212.446.1871
Optinose Investor Contact
Jonathan Neely
973.722.4356
MENAFN0712201700703653ID1096203862
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.